Burrill initiates coverage on Novavax (NASDAQ: NVAX) with a Market Outperform. PT $3.00.

"We view the company's recombinant protein ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE